H.C. Wainwright Adjusts BioXcel Therapeutics, Inc. (BTAI) Outlook Following Capital Structure Concerns

TheFly reported connected April 2 that H.C. Wainwright lowered its terms people connected BTAI to $5 from $6 portion maintaining a Buy rating. The steadfast attributed the revision to concerns implicit caller and expected equity dilution, which influenced its updated valuation outlook.

Separately, connected April 8, BioXcel Therapeutics, Inc. (NASDAQ:BTAI) announced that it has begun enrolling the archetypal patients successful a U.S. Department of War-funded Phase 2a objective survey evaluating BXCL501 for acute accent reactions. The proceedings is being conducted successful collaboration with the University of North Carolina astatine Chapel Hill Institute of Trauma Recovery and is designed arsenic a randomized, placebo-controlled survey enrolling astir 100 participants who acquisition trauma-related acute stress, specified arsenic aft centrifugal conveyance accidents.

The probe volition measure whether BXCL501 tin trim grounds severity, amended cognitive functioning, and assistance forestall progression to longer-term neuropsychiatric conditions similar post-traumatic accent disorder. The medicine is being supplied by the institution for the study. Acute accent reactions are communal successful some civilian and subject populations and correspond a ample unmet aesculapian need. The trial represents a cardinal measurement successful expanding objective probe for BXCL501 successful trauma-related psychiatric indications and advancing imaginable pharmacological attraction options.

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) is simply a clinical-stage biopharmaceutical institution that uses artificial quality to place and make caller therapies. It focuses connected neuroscience and immuno-oncology, advancing treatments for conditions specified arsenic agitation, schizophrenia, and cancer.

While we admit the imaginable of BTAI arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Healthcare Stocks to Buy and Hold for 3 Years and 10 Best Beaten Down Stocks to Invest successful According to Analysts.

Disclosure: None. Follow Insider Monkey connected Google News.